Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Cross-Sectional Study of Cell Surface Marker Expression in Participants With Autoimmune or Inflammatory Diseases

NCT03757065 is registered in ClinicalTrials.gov with Alpine Immune Sciences, Inc. as lead sponsor.

NCT NCT03757065
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03757065 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Cross-Sectional Study of Cell Surface Marker Expression in Participants With Autoimmune or Inflammatory Diseases
Lead sponsor
Alpine Immune Sciences, Inc.
Phase
Observational
Overall status
Completed
Start date
June 12, 2019
Completion date
October 25, 2019
Enrollment
14 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

crohn's disease, inflammatory myositis, multiple sclerosis, sjogren's syndrome, systemic lupus erythematosus, systemic sclerosis, ulcerative colitis